What is LOPJLB’s current signal on HROW?

LOPJLB publishes daily direction and regime signals for HROW on this page.

What market regime is HROW in?

LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.

Harrow Health, Inc. (HROW)

COMPARE

Healthcare · Drug Manufacturers - Specialty & Generic · NASDAQ · US

HROW

Loading signal…

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $1.1B
Beta: 0.24
P/E (TTM): -28.45

Short % float: 27.45%
Days to cover: 12.4
SI change: +3.7%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for…

Employees: 373
Headquarters: US
Founded: 2007
Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares out: 37.3M
Float: 75.9%

harrow.com ↗

Key executives

Mark L. Baum — CEO, Chairman of the Board & Founder

Francis W. Mullery — President & Chief Executive Officer of Harrow's ImprimisRx Division

Andrew R. Boll — President, Chief Financial Officer & Corporate Secretary

SEC filings

EDGAR · CIK 13602140 · HROW

Analyst consensus

Buy

Bullish10100.0%

Neutral00.0%

Bearish00.0%

L $45.00Avg $66.50H $88.00

Target$66.50

FAQ

What is LOPJLB’s current signal on HROW?: LOPJLB publishes daily direction and regime signals for HROW on this page.
What market regime is HROW in?: LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
What does Harrow Health, Inc. (HROW) do?: Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several p…